Geneva, Switzerland

Jean Vizzavona

This inventor holds 1 USPTO granted patent. Top assignee: Atheris Laboratories, Dr. Reto Stocklin Et Sylvie Stocklin Associes. Active years: 2008.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean Vizzavona: Innovator in Polypeptide Purification

Introduction

Jean Vizzavona is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the purification of polypeptides. His innovative approach has the potential to enhance various applications in biotechnology and pharmaceuticals.

Latest Patents

Vizzavona holds a patent for the purification of polypeptides. This invention relates to a process for purifying a polypeptide, which includes a capture tag useful for the purification process. The patent describes a method that involves attaching the polypeptide to a purification matrix by contacting it with a matrix comprising aldehyde or ketone groups. This process is designed to favor the formation of a heterocyclic ring system, followed by washing the matrix and releasing the purified polypeptide.

Career Highlights

Jean Vizzavona is associated with Atheris Laboratories, where he works alongside Dr. Reto Stocklin and Sylvie Stocklin. His work at Atheris Laboratories focuses on advancing research in biochemistry and developing innovative solutions for polypeptide purification.

Collaborations

Some of his notable coworkers include Keith Rose and Matteo Villain. Their collaborative efforts contribute to the ongoing research and development in the field of biochemistry.

Conclusion

Jean Vizzavona's contributions to the purification of polypeptides exemplify the importance of innovation in the scientific community. His work not only advances the field of biochemistry but also opens new avenues for research and application in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…